Pharmaceutical company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | SANDOZ INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$170,000 | |
| 2026 | SANDOZ INC |
1st Quarter (Jan 1 - Mar 31) AMENDED |
$890,000 | |
| 2026 | SANDOZ INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$140,000 | |
| 2025 | SANDOZ INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$140,000 | |
| 2025 | SANDOZ INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$100,000 | |
| 2025 | SANDOZ INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$150,000 | |
| 2025 | SANDOZ INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$680,000 | |
| 2024 | SANDOZ INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$90,000 | |
| 2024 | SANDOZ INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$90,000 | |
| 2024 | SANDOZ INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$90,000 |
| Firm | Filings | Expenses |
|---|---|---|
| SANDOZ INC | 14 | $3,220,000 |
| Issue | Activities |
|---|---|
| Health Issues | 9 |
| Medicare/Medicaid | 5 |